Silencing of suppressor of cytokine signaling 1 enhances the immunological effect of mucin 1-calreticulin-primed 4T1 cell-treated dendritic cells in breast cancer treatment

In cancer immunotherapy, dendritic cell (DC)-based vaccines represent a promising, yet challenging, treatment method. In addition to overcoming the low expression levels of antigenic epitopes on cancer cells, it is also necessary to overcome the inhibitory effect of suppressor of cytokine signaling...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Song, Gao, Zhipeng, Liu, Yu, Liu, Changbai, Wang, Jun, Zou, Li Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774391/
https://www.ncbi.nlm.nih.gov/pubmed/29434859
http://dx.doi.org/10.3892/ol.2017.7477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774391/
https://www.ncbi.nlm.nih.gov/pubmed/29434859
http://dx.doi.org/10.3892/ol.2017.7477

Ejemplares similares